#aqch

[rnewsworldenglish]

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Solar Pharmaceutical Industries Ltd. which incorporates its subsidiaries and/or affiliate corporations has commenced Part-II scientific trial on AQCH, a phytopharmaceutical (plant-derived) drug for remedy for COVID-19.

The corporate had acquired approval from the Medication Controller Normal of India (DCGI) for conducting Part-II scientific trial in April this yr.

The scientific trial might…

View On WordPress

[gostcoder]

सन फार्मा टेस्टिंग प्लांट-आधारित ड्रग AQCH को संभावित कोविद -19 उपचार के रूप में

सन फार्मा टेस्टिंग प्लांट-आधारित ड्रग AQCH को संभावित कोविद -19 उपचार के रूप में

[ad_1]

प्रतिनिधित्व के लिए छवि। (छवि: रायटर)

AQCH उष्णकटिबंधीय, कोकबुलस हिरसुतस पर चढ़ने से प्राप्त होता है, जिसका उपयोग एशिया में इसके स्पष्ट औषधीय गुणों के लिए किया जाता है।

रायटर बेंगलुरु

आखरी अपडेट: 5 जून, 2020, 12:56 PM IST

भारतीय दवा निर्माता सन फार्मास्युटिकल इंडस्ट्रीज लिमिटेड ने शुक्रवार को कहा कि यह एक मिड-स्टेज ट्रायल के हिस्से के रूप में COVID-19 के संभावित उपचार के लिए…

View On WordPress

[rnewsworldenglish]

Sun Pharma Testing Plant-based Drug AQCH as Potential Covid-19 Treatment

Sun Pharma Testing Plant-based Drug AQCH as Potential Covid-19 Treatment

Picture for illustration. (Picture: Reuters)

AQCH is derived from tropical, climbing shrub cocculus hirsutus, which is utilized in Asia for its obvious medicinal properties.

Reuters Bengaluru

Final Up to date: June 5, 2020, 12:56 PM IST

Indian drugmaker Solar Pharmaceutical Industries Ltd stated on Friday it was testing a plant-derived drug, AQCH, for the potential…

View On WordPress

[newscountryindia]

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment Sun Pharma received approval from regulator DCGI for the AQCH trial in April, data showed Bengaluru: …

[news24fresh]

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

[ad_1]

Sun Pharmaceutical Industries Ltd. which includes its subsidiaries and/or associate companies has commenced Phase-II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for treatment for COVID-19.

The company had received approval from the Drugs Controller General of India (DCGI) for conducting Phase-II clinical trial in April this year.

The clinical trial will be…

View On WordPress